首页> 外文期刊>Urology >Operative safety and oncologic outcome of laparoscopic radical nephrectomy for renal cell carcinoma 7 cm: A multicenter study of 222 patients
【24h】

Operative safety and oncologic outcome of laparoscopic radical nephrectomy for renal cell carcinoma 7 cm: A multicenter study of 222 patients

机译:腹腔镜根治性肾切除术治疗> 7 cm肾细胞癌的手术安全性和肿瘤学结果:222例患者的多中心研究

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To evaluate the safety of laparoscopic radical nephrectomy (LRN) for renal cell carcinoma (RCC) >7 cm, addressing the issue of modality and risk factors for complications and open conversion, and to assess the oncologic outcome. Methods: The data of 222 patients undergoing LRN for RCC >7 cm prospectively enrolled from 2002 to 2010 at 5 urologic centers were reviewed. Transperitoneal LRN was performed by 5 experienced laparoscopic surgeons. The Clavien-Dindo classification was used to assess complications. Multivariable analysis of factors predictive of conversions was performed. Oncologic outcomes for survival were estimated using the Kaplan-Meier method. Results: Median tumor size was 8.5 cm, operative time was 180 minutes, and blood loss was 280 mL. Forty-two patients (19%) received a blood transfusion. Six (2.7%) patients had grade III-IV complications: 2 with postoperative bleeding requiring abdominal re-exploration and 1 each with adrenal injury, splenic injury, wound diastasis, and respiratory insufficiency. Twelve patients (5.4%) were converted to open surgery. The diameter was 11.9 in converted groups and 8.5 cm in nonconverted groups (P =.001). Multivariable analysis revealed that pathologic stage was the only independent predictor of conversion (P =.002). The 5-year overall (OS), cancer-specific (CSS), and progression-free (PFS) survival was 74%, 78%, and 66%, respectively. The 5-year stage-adjusted CSS was 89% in pT2 and 40% in pT3 patients (P <.0001). Limitations of this study were its retrospective nature and the relatively short follow-up period for oncologic outcome. Conclusion: LRN for large RCC is a safe operation. Stage pT3 is a risk factor for open conversion and is associated to significantly lower cancer-specific survival compared with pT2 stage.
机译:目的:评估腹腔镜根治性肾切除术(LRN)治疗> 7 cm的肾细胞癌(RCC)的安全性,解决模式和并发症及开放转换的危险因素的问题,并评估肿瘤学结局。方法:回顾性分析了2002年至2010年在5个泌尿科中心接受222例接受RCC> 7 cm的LRN的患者的数据。 5名经验丰富的腹腔镜外科医生进行了腹膜LRN。 Clavien-Dindo分类用于评估并发症。对预测转化的因素进行了多变量分析。使用Kaplan-Meier方法评估生存的肿瘤学结局。结果:中位肿瘤大小为8.5 cm,手术时间为180分钟,失血量为280 mL。四十二名患者(占19%)接受了输血。六名(2.7%)患者患有III-IV级并发症:2例术后出血需要腹部再探查,1例患有肾上腺损伤,脾损伤,伤口转移和呼吸功能不足。 12名患者(5.4%)被转为开放手术。转换组的直径为11.9,非转换组的直径为8.5 cm(P = .001)。多变量分析显示,病理阶段是转化的唯一独立预测因子(P = .002)。 5年总生存期(OS),癌症特异性(CSS)和无进展生存期(PFS)分别为74%,78%和66%。经5年分期调整的CSS在pT2患者中为89%,在pT3患者中为40%(P <.0001)。该研究的局限性是其回顾性和肿瘤结局随访时间相对较短。结论:用于大型RCC的LRN是安全的操作。 pT3期是开放转化的危险因素,与pT2期相比,其癌症特异性生存率显着降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号